# Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules

> **NCT02169271** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 109 (actual)

## Conditions studied

- Current Smoker
- Former Smoker
- Multiple Pulmonary Nodules
- Tobacco Use Disorder

## Interventions

- **DRUG:** Aspirin
- **OTHER:** Laboratory Biomarker Analysis
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02169271
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11-21
- **Primary completion:** 2018-07-13
- **Final completion:** 2020-02-14
- **Target enrollment:** 109 (ACTUAL)
- **Last updated:** 2020-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02169271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02169271, "Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02169271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*